Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

December 06, 2013 16:30 ET | Source: Progenics Pharmaceuticals Inc.

Progenics Pharmaceuticals Announces That Data From a Phase I Study of Its 1404 Imaging Agent Has Been Presented at the Society for Urologic Oncology Meeting

– Progenics' Imaging Agent Correctly Identified the Presence of Primary Prostate Cancer in 100% of Phase I Study Subjects – Progenics Also Announces That Topline Data From a...
December 06, 2013 15:30 ET | Source: Progenics Pharmaceuticals Inc.

Progenics Pharmaceuticals Announces Completion of Enrollment of Chemotherapy Experienced Cohort in Phase II PSMA ADC Clinical Trial in Prostate Cancer

– Top-line Data in Chemotherapy Experienced Patients to be Presented at Oncology Meeting in January 2014 – Additional Cohort in Chemotherapy Naive Patients Has Been...
November 25, 2013 05:59 ET | Source: Progenics Pharmaceuticals Inc.

Progenics Pharmaceuticals Relaunching Registrational Trial of Azedra to Treat Pheochromocytomas

TARRYTOWN, N.Y., Nov. 25, 2013 (GLOBE NEWSWIRE) -- Progenics Pharmaceuticals, Inc. (Nasdaq:PGNX) today announced that it is resuming a phase 2b clinical study of safety and efficacy of a novel...
November 11, 2013 07:30 ET | Source: Progenics Pharmaceuticals Inc.

Progenics Pharmaceuticals Announces Third Quarter Financial Results

TARRYTOWN, N.Y., Nov. 11, 2013 (GLOBE NEWSWIRE) -- Progenics Pharmaceuticals, Inc. (Nasdaq:PGNX) today announced its results of operations for the quarter and nine months ended September 30. Net...
November 04, 2013 16:30 ET | Source: Progenics Pharmaceuticals Inc.

Progenics Pharmaceuticals Sets Third Quarter Financial Results Conference Call for November 11

TARRYTOWN, N.Y., Nov. 4, 2013 (GLOBE NEWSWIRE) -- Progenics Pharmaceuticals, Inc. (Nasdaq:PGNX) announced that it will host a conference call and webcast to review third quarter financial results on...
September 11, 2013 16:00 ET | Source: Progenics Pharmaceuticals Inc.

Progenics Pharmaceuticals Announces a Changing of the Guard on Its Board Of Directors

-Michael Kishbauch, former CEO of Achillion, joins Board -Stephen Goff retires from Board following 20 years of service TARRYTOWN, N.Y., Sept. 11, 2013 (GLOBE NEWSWIRE) -- Progenics...
September 05, 2013 16:14 ET | Source: Progenics Pharmaceuticals Inc.

Progenics Pharmaceuticals to Present at Stifel Healthcare Conference

TARRYTOWN, N.Y., Sept. 5, 2013 (GLOBE NEWSWIRE) -- Progenics Pharmaceuticals, Inc. (Nasdaq:PGNX) chief executive officer Mark R. Baker will make a presentation on Thursday, September 12 at 1:30 PM EDT...
August 09, 2013 07:30 ET | Source: Progenics Pharmaceuticals Inc.

Progenics Pharmaceuticals Announces Second Quarter 2013 Financial Results

TARRYTOWN, N.Y., Aug. 9, 2013 (GLOBE NEWSWIRE) -- Progenics Pharmaceuticals, Inc. (Nasdaq:PGNX) today announced its results of operations for the quarter and six months ended June 30, 2013. Net loss...
August 02, 2013 08:00 ET | Source: Progenics Pharmaceuticals Inc.

Progenics Pharmaceuticals Second Quarter Conference Call Set for August 9

TARRYTOWN, N.Y., Aug. 2, 2013 (GLOBE NEWSWIRE) -- Progenics Pharmaceuticals, Inc. (Nasdaq:PGNX) will host a conference call and webcast to discuss its financial results for the second quarter 2013 on...
July 16, 2013 13:59 ET | Source: Progenics Pharmaceuticals Inc.

Progenics Pharmaceuticals to Webcast Investor and Analyst Day July 18, 2013

TARRYTOWN, N.Y., July 16, 2013 (GLOBE NEWSWIRE) -- Progenics Pharmaceuticals, Inc. (Nasdaq:PGNX) will webcast its upcoming investor and analyst day, taking place July 18, 2013 from 2:30pm –...